-
Ozempic, Wegovy not tied to higher risk of suicidal thoughts: NIH study
Contrary to some anecdotal reports, a new study has found semaglutide — the active ingredient in blockbuster weight loss drugs Ozempic and Wegovy — is not linked to increased risks of suicidal thoughts. -
Florida becomes 1st state authorized by FDA to import meds from Canada
Florida has become the first state authorized by the FDA to import prescription drugs from Canada after the agency issued an approval of the Sunshine State's drug importation program Jan. 5. -
Eli Lilly to sell weight loss drugs directly to consumers; warns against 'cosmetic' usage
Eli Lilly has launched a new website for customers with migraines, obesity and diabetes to order prescription drugs directly from the manufacturer, including weight loss medications such as Zepbound. -
Walgreens ready to embrace 'Cost Plus' drug model, CEO says
Walgreens' new CEO Tim Wentworth says the pressure is on to develop new drug pricing models following a recent shift in the retail pharmacy market "to give patients the Cost Plus experience." -
FDA probes hair loss, other potential weight loss drug side effects
The FDA is looking into whether hair loss, aspiration and suicidal thoughts may be side effects of GLP-1 receptor agonists, a popular class of weight-loss drugs. -
A new weapon in the war against drug-resistant bacteria
Scientists have developed a new antibiotic, zosurabalpin, to attack a notoriously drug-resistant family of bacteria known as carbapenem-resistant Acinetobacter baumannii, or CRAB for short, which kills many of those it infects. -
Patient advocate Dr. Sidney Wolfe dies at 86
Sidney M. Wolfe, MD, who fought the FDA and pharmaceutical industry over high drug prices and dismissed health hazards for more than four decades, died at 86 years old, The New York Times reported. -
Pfizer to lay off 285 in New York
Pfizer will lay off more than a fourth of its employees at a New York facility, according to a WARN notice filed in the state. -
Colorado system turns to apprenticeships to ease tech shortage
Children's Hospital Colorado did not have the resources to pay pharmacy techs more or create a training program, so it established apprenticeships to solve the workforce shortage. -
Mark Cuban's drug company now sells 2K medications: What to know
Since launching in January 2021 with about 100 generics, Mark Cuban Cost Plus Drug Co. now offers more than 2,000 drugs, including about a dozen brand-name medications. -
FDA warns of infection risk over fake Ozempic
The FDA is warning clinicians and pharmacies about possible infection risks tied to counterfeit versions of the weight loss drug Ozempic. -
Experts warn of disruptions amid discontinuation of popular inhaler
At the start of 2024, GSK is discontinuing Flovent, its popular branded asthma inhaler, and switching to a generic version. The generic is virtually identical, though physicians are worried that delays in securing insurance coverage will cause disruptions for patients, CNN reported Dec. 28. -
Bristol Myers to buy cancer therapy company for $4B
In an effort to expand its cancer treatment offerings, Bristol Myers Squibb plans to acquire RayzeBio, a radiopharmaceutical therapeutics company. The deal is worth $4.1 billion, the companies announced Dec. 26. -
Outpatient Pharmacy Services and Expanded Strategic Partnerships Show Clinical and Financial Promise for Health Systems
In the face of modern challenges, expanding outpatient retail pharmacy services and exploring nontraditional partnerships present a growing opportunity for health systems to better patient outcomes, generate much-needed revenue, and safeguard themselves from added financial risk. -
Thousands overdosed on weight loss drugs in 2023
The number of overdoses from Ozempic and Wegovy nearly quadrupled between 2021 and 2023, according to poison center data reported by The Los Angeles Times. -
Scientists at UC San Diego work to refine acne vaccine
Researchers at the University of California San Diego School of Medicine found positive results from a trial of a vaccine to treat acne in mice, the institution announced Dec. 20. -
Rite Aid barred from using facial recognition for 5 years
Rite Aid has entered a proposed settlement with the Federal Trade Commission to resolve allegations the drug store chain improperly used facial recognition technology to identify potential shoplifters. -
Paxlovid halved deaths, hospitalizations with optimal timing: Study
Pfizer's COVID-19 antiviral Paxlovid cut the prevalence of hospitalizations and deaths in half when it was used within the first day of diagnosis, according to a study published Dec. 16 in Nature. -
Older weight loss drugs rise in popularity in Ozempic era
Amid the rise of the Ozempic, Wegovy and Mounjarno, older weight loss drugs are making a comeback in 2023, just like ripped jeans. -
Wegovy, other GLP-1s could lower heart disease: Study
A popular class of drugs for weight loss and Type 2 diabetes might help lower the prevalence of heart disease, according to a study published Dec. 18 in Cell Metabolism.
Page 21 of 50